Royal Bank of Canada’s Redhill Biopharma RDHL Stock Holding History

Royal Bank of Canada’s Portfolio RDHL Stock Details RDHL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$0	Hold	1	–	–	﹤0.01%	7591
2025 Q4	$0	Hold	1	–	–	﹤0.01%	7549
2025 Q3	$0	Sell	1 -3	-75%	-$5	﹤0.01%	7451
2025 Q2	$0	Hold	4	–	–	﹤0.01%	7288
2025 Q1	$0	Hold	4	–	–	﹤0.01%	7171
2024 Q4	$0	Buy	4 +1	+33%	+$8	﹤0.01%	7187
2024 Q3	$0	Sell	3 -14	-82%	-$138	﹤0.01%	7327
2024 Q2	$0	Buy	17 +9	+113%	+$100	﹤0.01%	7448
2024 Q1	$0	Buy	8 +2	+33%	+$36	﹤0.01%	7487
2023 Q4	$0	Sell	6 -84	-93%	-$1.71K	﹤0.01%	7497
2023 Q3	$1K	Buy	90 +84	+1,400%	+$2.2K	﹤0.01%	6930
2023 Q2	$0	Buy	6 +1	+20%	+$58	﹤0.01%	7586
2023 Q1	$0	Hold	5	–	–	﹤0.01%	7404
2022 Q4	$1K	Buy	5 +1	+25%	+$433	﹤0.01%	7071
2022 Q3	$3K	Buy	4 +3	+300%	+$2.61K	﹤0.01%	6915
2022 Q2	$1K	Sell	1 -1	-50%	-$1.37K	﹤0.01%	7186
2022 Q1	$4K	Sell	2 -1	-33%	-$2.37K	﹤0.01%	7333
2021 Q4	$8K	Sell	3 -2	-40%	-$8K	﹤0.01%	7119
2021 Q3	$25K	Hold	5	–	–	﹤0.01%	6581
2021 Q2	$38K	Hold	5	–	–	﹤0.01%	6216
2021 Q1	$36K	Sell	5 -1	-17%	-$8.39K	﹤0.01%	6094
2020 Q4	$46K	Sell	6 -1	-14%	-$8.99K	﹤0.01%	5691
2020 Q3	$68K	Buy	7 +2	+40%	+$16.4K	﹤0.01%	5201
2020 Q2	$36K	Buy	5 +1	+25%	+$6.89K	﹤0.01%	5364
2020 Q1	$19K	Buy	4 +1	+33%	+$5K	﹤0.01%	5575
2019 Q4	$18K	Hold	3	–	–	﹤0.01%	5905
2019 Q3	$21K	Hold	3	–	–	﹤0.01%	5488
2019 Q2	$19K	Hold	3	–	–	﹤0.01%	5746
2019 Q1	$25K	Hold	3	–	–	﹤0.01%	5550
2018 Q4	$16K	Hold	3	–	–	﹤0.01%	5683
2018 Q3	$26K	Buy	+3	New	+$24.4K	﹤0.01%	5550
2018 Q2	–	Hold	0	–	–	–	6106
2018 Q1	–	Hold	0	–	–	–	6121
2017 Q4	–	Hold	0	–	–	–	6291
2017 Q3	–	Hold	0	–	–	–	6469
2017 Q2	–	Hold	0	–	–	–	6202
2017 Q1	–	Hold	0	–	–	–	6291
2016 Q3	–	Sell	-21	Closed	-$228K	–	6549
2016 Q2	$228K	Hold	21	–	–	﹤0.01%	4325
2016 Q1	$259K	Hold	21	–	–	﹤0.01%	4185
2015 Q4	$270K	Hold	21	–	–	﹤0.01%	4315
2015 Q3	$271K	Hold	21	–	–	﹤0.01%	4066
2015 Q2	$369K	Buy	+21	New	+$333K	﹤0.01%	3893

Other funds holding RDHL

YAG

Yorkville Advisors Global Mountainside, New Jersey $155M AUM 58.46% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

StoneX Group New York $1.86B AUM 21.3% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada's RDHL Position: Q1 2026 in Review

Royal Bank of Canada held its Redhill Biopharma (RDHL) position steady in Q1 2026 at 1 share worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #7591.

Royal Bank of Canada first reported a position in RDHL in Q2 2015 and has held it in 36 quarters since. The position peaked at $369K in Q2 2015. 16 funds tracked by Wall St. Rank hold RDHL as of Q1 2026.

Royal Bank of Canada held 1 share of Redhill Biopharma worth $0 as of Q1 2026.
Royal Bank of Canada left its Redhill Biopharma share count unchanged in Q1 2026.
Redhill Biopharma made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #7591 holding.
Royal Bank of Canada first reported a position in Redhill Biopharma in Q2 2015 and has held it in 36 quarters since.
Royal Bank of Canada's Redhill Biopharma position peaked at $369K in Q2 2015.
16 funds tracked by Wall St. Rank held Redhill Biopharma as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.